Development of a monoclonal antibody-based co-agglutination test to detect enterotoxigenic Escherichia coli isolated from diarrheic neonatal calves by Varshney, Brajesh C. et al.
JOURNAL OF
Veterinary 
Science
J. Vet. Sci. (2007), 8(1), 57–64
Development of a monoclonal antibody-based co-agglutination test to detect 
enterotoxigenic Escherichia coli isolated from diarrheic neonatal calves
Brajesh C. Varshney
1,*, N.M. Ponnanna
2, Pranati A. Sarkar
2, Pragna Rehman
2, Jigar H. Shah
2
1Intas Biopharmaceuticals Ltd., Plot No. 423/P/A/GIDC, Sarkhej-Bavla Highway, Moraiya, Ahmedabad-382 210, Gujarat, India
2R&D, Biotechnology, National Dairy Development Board, Anand-388 001, Gujarat, India
Escherichia coli ( E. coli) strains were collected from
young diarrheic calves in farms and field. Strains that
expressed the K99 (F5) antigen were identified by
agglutination tests using reference antibodies to K99
antigen and electron microscopy. The K99 antigen from a
selected field strain (SAR-14) was heat-extracted and
fractionated on a Sepharose CL-4B column. Further
purification was carried out by sodium deoxycholate
treatment and/or ion-exchange chromatography.
Monoclonal antibodies to purified K99 antigen were
produced by the hybridoma technique, and a specific
clone, NEK99-5.6.12,
  was selected for propagation in
tissue culture. The antibodies, thus obtained, were
affinity-purified, characterized and coated onto Giemsa-
stained Cowan-I strain of Staphylococcus aureus (S.
aureus). The antibody-coated S. aureus were used in a co-
agglutination test to detect K99+ E. coli isolated from
feces of diarrheic calves. The specificity of the test was
validated against reference monoclonal antibodies used in
co-agglutination tests, as well as in ELISA. Specificity of
the monoclonal antibodies was also tested against various
Gram negative bacteria. The developed antibodies
specifically detected purified K99 antigen in immunoblots,
as well as K99+ E. coli in ELISA and co-agglutination
tests. The co-agglutination test was specific and convenient
for large-scale screening of K99+ E. coli isolates.
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Introduction
Diarrhea-causing  Escherichia coli ( E. coli) possess
colonization antigens or adhesins that enable the bacteria to
colonize the small intestines [3]. The K99 (F5) fimbrial
antigen has been reported to be associated with a majority of
enterotoxigenic  E. coli (ETEC) isolated from cases of
diarrhea in neonatal calves [1,8].
In India, diarrhea in calves poses a major threat to the
health of the animals and leads to economic loss. Little
systematic work has been done to obviate this threat. One
reason could be the absence of diagnostic tests to detect
pathogenic E. coli strains. While there are some reports on
human ETEC infections in India [4,9,10], very little
information is available on ETEC-mediated diarrhea in
neonatal calves [12].
A number of diagnostic tests are currently available for
detecting ETEC. Double-antibody enzyme-linked immuno-
sorbent assay (ELISA) was developed to detect the K99
pilus antigen [7]. DNA gene probes specific for genes
encoding toxins and adhesins of ETEC [27] and multiplex
polymerase chain reaction (PCR) for the rapid screening of
ETEC toxins [24,26] have also been used with a fair amount
of success. However, these tests require proper facilities and
some amount of scientific expertise to conduct and interpret
the test results. Therefore, we developed a simple but
specific test to detect K99+ E. coli recovered from feces of
diarrheic calves. The K99 fimbrial antigen was isolated and
purified, monoclonal antibodies (MAbs) were produced
against K99, and a co-agglutination test was developed to
detect K99+ E. coli.
Materials and Methods
Bacteria, media and antibodies
E. coli were isolated from fecal samples collected from
diarrheic calves. The isolates were grown in Minca-
Isovitalex medium as described by Guinee et al. [6]; the
medium was supplemented with 1 g of yeast extract (Oxoid)
per liter of medium.
K99+ E. coli isolates were initially identified by agglutination
tests using K99 antiserum obtained from the National
Institute of Public Health and Environmental Protection
(Netherlands), and subsequently confirmed by electron
microscopy. K99 antigen was isolated and purified from a
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field isolate, designated SAR-14, which exhibited strong
agglutination with K99 antiserum. The reference K99 (F5)
MAb was procured from the Central Veterinary Laboratory
(CVL), UK.
Electron microscopy 
Electron microscopy was carried out as described by
Korhonen et al. [11]. SAR-14, a wild strain of E. coli, was
grown in Minca-Isovitalex media, prepared as described by
Guinee  et al. [6]; for 17 h, stained with 1% (w/v)
phosphotungstic acid and examined in a electron microscope
(JEM 100; Jeol, Japan) at an operating voltage of 80 kV.
Isolation of K99 antigen from a wild strain of E. coli
The SAR-14 strain of E. coli was grown in 3.0 l of Minca-
Isovitalex broth for 17 h at 37
oC (O.D.660= 1.6). The bacteria
were then harvested by centrifugation at 6,000 g and
resuspended in phosphate urea buffer (50 mM phosphate
buffer, pH 7.2 with 2 M urea) at O.D.660= 100. The
suspension was heated at 60
oC for 20 min and centrifuged at
30,000 × g for 15 min. The sediment was discarded, while
the K99 antigen in the supernatant was precipitated with
ammonium sulfate, separated and dialyzed as per Morris  et
al. [17].
Gel filtration chromatography
A glass column (Pharmacia, Sweden) measuring 60 cm in
length by 1 cm in diameter was packed with Sepharose CL-
4B (Pharmacia, Sweden) to a bed volume of 35 ml with a
peristaltic pump. The packed column was washed with
sodium phosphate buffer (50 mM, pH 7.2) and equilibrated
with several column volumes of phosphate buffer
containing 2 M urea (PUB). The salt-precipitated bacterial
proteins (in PUB) were gently loaded on the column and 60
fractions of 1-ml were collected.
Spectrophotometric readings of each fraction were taken
at 280 nm. Fractions constituting individual peaks were
pooled and analyzed for K99 antigen. Concentrated, pooled
fractions were dialyzed for 72 h against phosphate-
deoxycholate (DOC) buffer (phosphate buffer, pH 7.5
containing 0.5% sodium deoxycholate) after addition of
DOC to the fraction [0.5% DOC (w/v)]. The purity of the
fractions was checked by SDS-PAGE. 
Fast protein liquid chromatography (FPLC)
The FPLC system (Amersham Pharmacia Biotech, USA)
equipped with cation exchange column MonoS HR 5/5 was
used for purification. The column was equilibrated in buffer
A (10 mM phosphate buffer, pH 7.2), and bound proteins
were eluted in buffer B (10 mM phosphate buffer containing
250 mM NaCl) with a phosphate buffer-NaCl gradient of 0-
100%.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE)
SDS-PAGE gels were prepared by the Laemmli method
[13] with the modification of Lugtenberg et al. [14].
Electrophoresis was carried out after loading 2 µg of sample
per lane, along with a lane of standard molecular weight
markers (10 kDa ladder; Gibco BRL, USA). Gels were
stained with Coomassie Brilliant Blue.
Immunoblotting 
Crude and purified protein fractions were subjected to
Western blotting as described by Sambrook et al. [20].
Proteins were separated by electrophoresis on SDS-
polyacrylamide gels and transferred to nitrocellulose membrane
using LKB 2117 Electrophoresis unit, NOVABLOT
(Pharmacia, Sweden). Membranes were incubated with
blocking solution (1% skimmed milk powder in distilled
water) for 2 h to avoid non-specific binding. The reference
anti-K99 MAbs (CVL, UK) were diluted 1 : 500 and
incubated with the membrane for ~2 h. After washing with
Tris-Cl buffer, pH 7.5, rabbit anti-mouse IgG (diluted
1 : 1,000 with Tris-Cl buffer) conjugated with horseradish
peroxidase (HRPO) was incubated with the membranes for
2 h at ambient temperature. The proteins were then stained
with the HRPO substrate diaminobenzidine.
Dot immunoblots 
Protein fractions eluted from the Sepharose CL-4B
column were dotted on nitrocellulose membranes. The dot-
blots were sequentially incubated with standard anti-K99
MAbs and rabbit anti-mouse IgG-HRPO conjugate and
developed as described above.
Hyper-immunization of rabbit with K99 antigen
A healthy 12-week-old female New Zealand White rabbit
was selected for raising polyclonal antibodies against
purified K99 antigen. Pre-immune serum was collected and
stored at −20
oC after addition of sodium azide (0.005%).
About 100 µl of purified K99 antigen (~200 µg protein) was
emulsified with 100 µl of Titermax (CytRx, USA) adjuvant
and injected intramuscularly in both hind legs of the rabbit.
Thereafter, injections of 50 µg purified K99 antigen in
100 µl of PBS pH 7.3 were given intravenously on days 31,
38 and 47.
Serum samples were collected on days 14, 21, 29, 44 and
55, and antibody titers were estimated by ELISA. The final
bleed was collected on day 65, and the serum was preserved
at −20
oC.
Monoclonal antibody production 
Hybridoma technology [15] was used to produce K99-
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emulsified with Titermax adjuvant and injected intramuscularly
in 8-week-old BALB/c mice twice with a 3-week interval.
This procedure was followed by two intravenous inoculations
of 20 µg and 30 µg of antigen, respectively, with a 3-day
interval. The mice were regularly bled to assay antibody
titers and, when sufficient titers had developed (~ 2 months),
the mice were sacrificed and their spleens were removed
aseptically. Hybridomas were produced by polyethylene
glycol-mediated fusion of spleen cells with the mouse
plasmacytoma cell line SP2O1-Ag-14. The resulting
hybridomas were grown in selective medium containing
hypoxanthine, aminopterin and thymidine in 24-well tissue
culture plates. Supernatants from wells containing hybridoma
clones were assayed for K99-reactive antibodies by ELISA
using purified K99 as the antigen. A specific clone,
designated NEK99-5.6.12, was selected and propagated in
large tissue-culture flasks. The secreted antibodies were
harvested by centrifugation at 5,000 × g, precipitated with
ammonium sulfate (45% saturation) and dialyzed against
phosphate buffer, pH 7.2. The antibodies were affinity-
purified on a Protein G Sepharose column (Pierce, USA.)
and subsequently characterized by ELISA using the mouse
monoclonal antibody isotyping kit (ISO-2; Sigma, USA).
ELISA for screening of hybridoma culture supernatants
Polystyrene microtiter plates (Maxisorp; Nunc, Denmark)
were coated with 100 ng/well of purified K99 antigen and
blocked with 200 µl of 1% skimmed milk powder. Tissue
culture supernatants were added to individual wells and the
plates incubated for 2 h at 37
oC. After washing, 100 µl of
HRPO-conjugated rabbit anti-mouse IgG (diluted 1 : 1000)
was added. The plates were incubated for 2 h at 37
oC, then
washed, and the substrate, tetramethyl benzidine with H 2O2
(Genei, India) diluted 1 : 20 in distilled water, was added.
The reaction was terminated with 50 µl 1 N H2SO4, and the
plates were read in an ELISA reader (Titertek Multiskan;
Titertek, Finland) at 490 nm. Standard monoclonal antibodies
were used as positive controls and growth medium was used
as the negative control.
Antigen capture ELISA
Microtiter plates were coated with an optimal concentration
(~200 ng/well) of affinity-purified IgG from sera of rabbits
hyper-immunized with purified K99 antigen. Adequate
concentration (~2 × 10
5 cells/well) of bacterial cells from
different isolates were added to duplicate wells and
incubated for 2 h at 37
oC. The wells were then washed with
Tris-Cl buffer, pH 7.5, and standard monoclonal antibodies
(CVL, UK) or test monoclonal antibodies (tissue culture-
derived) were added to each of the duplicate wells, respectively.
After incubation and washing, rabbit anti-mouse-HRPO
conjugate was added, and the reactions were developed by
substrate addition as described above. A standard E. coli
strain positive for K99 expression (ATCC 31616) was used
as positive control, and the laboratory E. coli strain HB101
was used as negative control.
The co-agglutination test
The adopted protocol was that described by Batra et al.
[2], which was developed to detect Brucella antigens.
Briefly, cells were harvested from overnight cultures of
Staphylococcus aureus (S. aureus) Cowan I strain, washed
in 0.01 M PBS pH 7.2 and resuspended at 5% (v/v) in the
same buffer. Cells were sequentially treated with formalin
(2% v/v, overnight at 4
oC) and heat (80
oC for 5 min) and
then stained with Giemsa for 6 h at 4
oC. Stained cells were
again washed and adjusted to 5% v/v in PBS. The cells were
coated with purified reference or tissue culture-derived
monoclonal antibodies at varying concentrations (0.5 to
5 mg), incubated at 37
oC for 2 h and washed to remove
unbound antibodies. Aliquots of the monoclonal antibody-
coated S. aureus were kept at 4
oC and at room temperature.
Ten microliters of this suspension was mixed with 10 µl of
bacterial suspension derived from feces of diarrheic calves
on a test card. Agglutination appearing within a minute was
considered a positive reaction. Positive and negative controls
were the same as those used in antigen capture ELISA.
For hybridoma work, mice experiments were conducted
according to the norms of “Committee for the Purpose of
Control and Supervision of Experiments on Animals,”
Government of India, Ministry of Environment & Forests,
Animal Welfare Division. Approval was obtained from the
Institutional Animal Ethics Committee under Project
Proposal No. 12/Departmental Proposal No. AH11.
Results
Following growth in Minca-Isovitalex broth for 17 h,
fimbriae on E. coli strain SAR-14 were observed by electron
microscopy (Fig. 1). The fimbriae exhibited agglutination
with standard reference K99 monoclonal antibody. When
grown in Nutrient agar or MacConkey agar, the SAR-14
strain did not agglutinate with K99 antiserum. Therefore,
Minca-Isovitalex medium was appropriate for E. coli
fimbrial K99 antigen expression.
Heat treatment of fimbriated E. coli for 20 min at 60
oC in
the presence of 2 M urea effectively detached the fimbriae
from the host cells. Detachment was verified by SDS-
PAGE; a prominent 18.5-kDa band (the putative K99
antigen) was observed along with several minor higher
molecular weight proteins in the supernatants of bacterial
heat extracts (Fig. 2). The 18.5-kDa band was absent from
the pellet fraction (Fig. 2). Proteins in the supernatants were
further concentrated by ammonium sulfate precipitation
(60% saturation), which appeared to enrich the putative K99
antigen (Fig. 2).
The heat-extracted, salt-precipitated fimbrial antigens were
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with PBS, pH 7.2, containing 2 M urea. The proteins eluted
in one major and one minor peaks (Fig. 3). Fractions
comprising the two peaks were pooled separately and
aliquots of the two fractions were tested by immunoblotting
using reference MAbs to the K99 antigen. Dot blots
confirmed the presence of K99 antigen in the heat extract,
salt precipitate and the first sepharose gel-eluted protein
peak (Fig. 3). The column-eluted fractions were analyzed on
SDS polyacrylamide gel, which indicated that the first peak
contained the 18.5-kDa protein along with several minor
proteins of moderate sizes. The second peak contained
minor amounts of high molecular weight proteins (Fig. 2).
The 18.5-kDa protein was further purified by treatment with
sodium deoxycholate, which appeared to specifically
solubilize the 18.5 kDa protein (Fig. 2); minute amounts of a
~38-kDa protein also appeared to co-solubilize with the
18.5-kDa protein (Fig. 2). Complete purification of the
desired protein, from the major peak of sepharose gel-eluted
proteins, was achieved by FPLC using the cation-exchange
column MonoS HR 5/5. Two sharp peaks were observed on
FPLC analysis (Fig. 4). The first peak represented unbound
proteins, which appeared in the flow-through fraction. The
second peak represented bound proteins that eluted with
increasing concentrations of NaCl in the buffer. Dot-blot
analysis using reference K99 MAbs confirmed that only the
second peak contained K99 antigen (data not shown).
Finally, various fractions obtained throughout the purification
procedure were analyzed by Western blotting using reference
K99 MAbs. The single band migrating at ~18.5 kDa was
confirmed as purified K99 antigen (Fig. 5).
Fig. 1. Electron micrograph of E. coli strain SAR-14 showing
fimbriae. 1% phosphotungstic acid stain. × 40,000.
Fig. 2. SDS-PAGE of crude and purified fimbrial preparations.
Lanes: 1, heat-treated bacterial pellet; 2, proteins in heat-treate d
bacterial supernatant; 3, ammonium sulfate precipitate; 4 & 5,
proteins eluted from Sepharose CL-4B column fractions 1 & 2,
respectively; 6 & 7, protein profile following DOC treatment o f
fraction 1 supernatant & pellet, respectively; 8 & 9, protei n
profile following DOC treatment of fraction 2 supernatant &
pellet, respectively; M, Marker (10 kDa protein ladder).
Fig. 3. Elution profile of fimbrial extracts of E. coli on a
Sepharose CL-4B column (1.1 × 60 cm) equilibrated with
phosphate-urea buffer. (Inset): Dot blot assay of fimbrial extracts
to reference K99 monoclonal antibodies. lanes: 1, heat extract; 2,
ammonium sulfate precipitate; 3, ammonium sulfate supernatant;
4 & 5, gel filtration column elutes 1 & 2, respectively.
Fig. 4. Fast protein liquid chromatography: elution profile of the
E. coli K99 antigen from a cation exchange column. Column,
MonoS HR 5/5; equilibration buffer, 10 mM PBS, pH 7.2;
elution buffer, 10 mM PBS with 250 mM NaCl.; fraction size,
1.0 ml; flow rate, 1 ml/min.Monoclonal antibody-based test for detection of enterotoxigenic  E. coli 61
Purified K99 protein was used to immunize BALB/c mice
for MAb production. Actively growing hybrids were seen in
the microtiter plates a week after fusion of mouse spleen
cells with myeloma cells. Supernatants from these hybrids
were collected and assayed for K99 reactivity by ELISA.
Two stable hybrids (Nos. 5 and 3) that produced large
amounts of K99-specific antibodies were selected and
cloned by limited dilution. Clones 5.6 and 3.8 were subcloned
twice and the final clones, designated NEK99-5.6.12 and
NEK99-3.8.1, respectively, were cryopreserved in liquid
nitrogen. Antibodies derived from these two clones were
compared with the reference MAb (CVL, UK) in Western
blot analysis of proteins eluted from the gel filtration column
and FPLC-purified protein. The reactivity of both the tissue
culture-derived antibodies (5.6.12 and 3.8.1) was comparable
to that of the reference MAb (CVL, UK) (Fig. 6). Clone
NEK99-5.6.12 was selected for further applications. The
specificity of antibodies derived from this clone was
checked at each stage of subcloning and when cells were
revived after cryopreservation. 
The tissue culture-derived MAbs were identified as IgG1
subclass by standard isotype ELISA. The reference antibody,
known to have IgG2a specificity, gave the expected results
and showed maximum reactivity to IgG2a subclass (data not
shown).
Tissue culture-derived MAbs were purified by affinity
chromatography using protein G columns (Amersham
Biosciences, UK). The purified MAbs were tested for cross
reactivity to different Gram negative bacteria in Western blot
analyses. Whole cell lysates of E. coli (SAR-14), Pasteurella,
Enterobacter, Pseudomonas and Klebsiella were separated
by SDS-PAGE, and the proteins were transferred to a
nitrocellulose membrane. Tissue culture-derived MAbs
were allowed to bind to the membrane. The antibody
specifically reacted with the K99 antigen of E. coli and did
not bind to proteins from other Gram negative bacteria, with
the exception of a ~20 kDa protein in Klebsiella (Fig. 7).
Despite the cross-reactivity with Klebsiella antigen, these
bacteria are easily differentiable on classical media.
Various concentrations of purified monoclonal antibodies
from clone NEK99-5.6.12 were used to coat the S. aureus
Cowan I strain. We found that 0.5 µg of antibodies per mL
of  S. aureus suspension was adequate to elicit a positive
reaction with the standard K99+
 E. coli strain in a co-
agglutination test, reflecting the high sensitivity of the assay.
Antibody-coated S. aureus were stable for 3 months when
stored at ambient temperature (20
oC to 39
oC) and for more
than 5 months when stored at 4
oC.
The co-agglutination test was used in testing field isolates
for the presence of K99+ E. coli. The specificity of the tissue
culture-derived antibodies was also compared to that of the
reference monoclonal antibody when the two were
separately coated on colored Staphylococcus cells and tested
for agglutination of random field isolates. Both antibodies
Fig. 5. Western blot of E. coli fimbrial proteins probed with
reference K99 MAbs. Lanes: M, molecular weight marker (10
kDa protein ladder); 1, heat extract; 2, ammonium sulfate
precipitate; 3 & 4, gel filtration column fractions 1 & 2,
respectively; 5, FPLC purified K99 antigen.
Fig. 6. Western blot of E. coli fimbrial proteins probed with
different MAbs to the K99 antigen. Panel A: Reference MAb
(CVL), Panel B: MAb derived from clone 5.6.12, Panel C: MAb
derived from clone 3.8.1, Lanes: M, molecular weight  marke r
(10 kDa benchmark protein ladder); 1 & 2, gel filtration colum n
fractions 1 & 2, respectively; 3, FPLC purified K99 antigen.
Fig. 7. Western blot of whole cell lysates of Gram negative
bacteria probed with tissue culture-derived K99 MAbs (NEK99-
5.6.12). lanes: M, molecular weight marker (10 kDa benchmark
protein ladder); 1, E. coli (SAR-14 strain); 2, Pasteurella; 3,
Enterobacter; 4, Pseudomonas; 5, Klebsiella.62 Brajesh C. Varshney et al.
exhibited similar reactions for all 25 strains tested, except
for BOM-11.2/95, which reacted positively with the tissue
culture-derived MAb but did not react with the reference
MAb (Table 1).
Monoclonal antibodies prepared in the laboratory were
used in a double antibody sandwich ELISA to assess their
ability to identify K99+ E. coli present in fecal specimens
(Table 2). The results were compared with those obtained in
the co-agglutination test. A higher absorbance value (OD 450
> 0.7) was generally associated with a positive reaction in
co-agglutination test. However, two strains (KUS-5.1/95
and BOM-17/95) with absorbance values of 0.74 were
negative in the co-agglutination test; two others (BOM-5.1/
95 and BOM-59.1/95) had absorbance values of less than
0.7 but were positive in the co-agglutination test.
Discussion
Escherichia coli is a member of the normal gut flora in
humans and animals and its presence may have nutritional
significance [21]. However, it is difficult to distinguish these
bacteria from pathogenic E. coli using routine bacteriological
methods like light microscopy, colony morphology,
biochemical characteristics, etc. Still, it is important to
demonstrate the presence of pathogenic E. coli before
attributing it as a cause of colibacillosis. Virulence factors
associated with enterotoxigenic E. coli in calves have been
characterized, and the K99 antigen has been used to develop
sensitive tests for diagnosis or subunit vaccines [21].
Several procedures are available to obtain purified
bacterial fimbriae [1,22]. The major problem encountered
with these procedures is that isolated fimbriae may be
contaminated with outer membrane proteins, which are
Table 1. Co-agglutination test reaction of various E. coli isolates
with tissue culture-derived* and reference K99 (F5) monoclonal
antibodies
K99 (F5) MAbs
E. coli isolates
Indigenous
(tissue culture 
derived)
Reference
(Central Veterinary 
Laboratory, UK)
KUS-5.1/91 - -
KUS-6/91 ++ ++
KUS-10.1/91 - -
SHI-2/91 - -
SAR-14/91 ++ ++
SAR-15/91 - -
BOM-7/91 - -
BOM-17/91 - -
JBL-1.1/95 - -
JBL-3/95 + +
JBL-8/95 ++ ++
JBL-9/95 + +
JBL-10.1/95 + +
JBL-12/95 ++ ++
JBL-14.1/95 - -
JBL-16.1/95 ++ +
JBL-23.1/95 - -
BOM-5.1/95 ++ ++
BOM-8/95 ++ +
BOM-11.2/95 ++ -
BOM-14/95 - -
BOM-59.1/95 - -
BOM-79.1/95 - -
ATCC, 31616 ++ ++
HB 101 - -
*NEK99-5.6.12, -: no agglutination within 60 sec, +: agglutination
within 60 sec, ++: agglutination within 30 sec, standard  E. coli strains:
ATCC 31616 & HB101.
Table 2. ELISA test for screening bacterial cultures for the
presence of K99 antigen and its correlation with co-agglutination
tests using tissue culture-derived monoclonal antibodies* to the
K99 antigen
E. coli strain ELISA
(O.D.450)
Co-agglutination 
test
SAR-14/91 2# +++
SAR-15/91 1.13 -
KUS-5.1/91 0.74 -
KUS-10.1 0.64 -
KUS-11.2 0.76 +
JBL-1.1/95 0.64 -
JBL-3/95 0.92 ++
JBL-4/95 0.78 ++
JBL8-/95 0.78 ++
JBL-9/95 1.00 ++
JBL-10.1/95 1.30 ++
JBL-12/95 0.78 ++
JBL-16.1/95 0.83 ++
JBL-23.1/95 0.60 -
BOM-5.1/95 0.61 ++
BOM-7/95 1.43 ++
BOM-8/95 0.70 ++
BOM-11.2/95 0.74 ++
BOM-14/95 0.64 -
BOM-17/95 0.74 -
BOM-17.1/95 0.82 ++
BOM-59.1/95 0.59 ++
ATCC, 31616 1.35 ++
HB101 0.005 -
*NEK99-5.6.12, #: Out of range, -: no agglutination within 60 sec, +:
Agglutination within 60 sec, ++: agglutination within 30 sec, +++:
Immediate agglutination, standard E. coli strains: ATCC 31616 &
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difficult to remove due to their hydrophobic binding to
fimbriae. Gel filtration chromatography alone resulted into
only partial fractionation. Peak 1 contained many
contaminating proteins along with the K99 antigen.
Treatment with DOC, which acts similarly to Triton X-100,
appeared to specifically solubilize the K99 protein and not
the outer membrane proteins. However, minute amounts of
a ~38-kDa protein co-solubilized with the K99 antigen. This
was confirmed on Western blots, where this higher
molecular weight (Mw) protein reacted with three different
MAbs to the K99 antigen. This suggested that the high M w
protein is either a multimeric form of K99 protein or is
another fimbrial protein having shared epitopes with the
K99 antigen. Following FPLC purification, the high M w
protein was not observed in SDS gels, implying that the
former is more likely . The cation exchange column was
used because K99 protein is reported to have a pI value of
> 9 [1]. A combination of gel filtration and ion-exchange
chromatography, rather than detergent solubilization,
provided suitable, quicker, reproducible and complete
purification of the K99 antigen.
The purified K99 antigen was primarily composed of
protein subunits with an apparent molecular weight of
18,500 Daltons based on SDS polyacrylamide gel analysis.
There are variable reports regarding the molecular weight of
K99 antigen. de Graaf et al. [5] and Vazquez et al. [25]
found the molecular weight of K99 antigen to be 18,500 and
17,000 respectively. The latter report also suggests that a
single fimbrial subunit may occur in different conformations
and, thus, slightly different molecular weights may be found
upon SDS-PAGE analysis [25]. In the current work,
however, the presence of a single band with an apparent
molecular weight of 18.5 kDa on SDS-PAGE indicated the
purity of protein subunits; this protein was confirmed to be
K99 antigen by immunoblotting using MAbs for K99
antigen. The positive control used in both tests was E. coli
ATCC strain 31616 (K99+) and the negative control was
HB101 (K99-).
The MAb to K99 antigen was tested for cross reactivity
against whole cell lysates prepared from other Gram
negative bacteria. All Gram negative bacteria were non-
reactive to the MAb except Klebsiella. Cross reactivity
amongst different subunits of the fimbrial protein is known
to occur [19]. The fact that a MAb raised against E. coli
fimbrial protein cross-reacted with Klebsiella suggests that
there may be some common epitope(s) between the two.
Further research on fimbrial proteins can explain this
observation.
There are many advantages to preparing monoclonal
antibodies to K99 antigen. Apart from economic considerations
and the regular availability in adequate quantities, these
antibodies could be orally administered to neonatal calves to
reduce the economic losses of cattle owners during
outbreaks of enteric colibacillosis in unvaccinated herds.
Production of K99-specific antibody and development of
sensitive ELISAs to detect K99 fimbriae on ETEC cells
were reported earlier [5, 16]. Co-agglutination tests using
Staphylococcus aureus have been used to diagnose H.
pleuropneumonia infections in pigs, pneumococcal pneumonia
in humans and brucellosis in cattle [2]. MAbs also have
important applications in the detection of K99 adhesin of E.
coli in aqueous vaccines [23]. In the present work,
monoclonal antibodies raised against K99 antigen used in a
Staphylococci agglutination test specifically detected K99+
E. coli in fecal isolates from diarrheic calves. Antigen
capture ELISA confirmed the specificity of the co-
agglutination test. A combination of polyclonal and
monoclonal antibodies was used in the antigen capture
ELISA; polyclonal antibodies were used as capture
antibodies and monoclonal antibodies were used as detector
antibodies, as suggested by Raybould et al. [18].
Staphylococci coated separately with tissue culture-
derived and reference K99 MAbs reacted similarly in co-
agglutination tests against various field isolates, except
against the isolate, BOM-11.2/95. It is not clear whether
there is subclass specificity between the 2 MAbs. The MAb
we developed is IgG1, whereas the reference MAb is IgG2a.
The co-agglutination test that we developed provides
convenient, simple and rapid screening of fecal isolates for
presence of K99+
 E. coli. It does not require expensive
facilities and can therefore be used cost-effectively. This test
could have important applications in epidemiological
studies where the incidence of enterotoxigenic E. coli in a
particular region can be studied. Based on incidence rates,
decisions could then be made for the development and use
of a vaccine to prevent and control colibacillosis in calves.
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